No insider purchase over the last 90 days. The latest was filed 19 Nov 2024.
This page follows insider dealings at AdvanSix Inc. as filed with SEC (Form 4), a company from the Chemicals & Materials sector. Between 18 October 2025 and 18 October 2026, 15 insiders published 25 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Compared with its exchange (5,810 companies, median 19 filings), a count of 25 filings is above the norm. Our records for AdvanSix Inc. go back to 2021, with 2 purchases and 54 sales on the open market in total. The 10-K for the year ended 31 December 2025 shows 1.52 bn USD of revenue and 49.3 m USD of net income.
Insider buying of AdvanSix Inc. has been absent for the past year. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction.
Elsewhere in the same sector, our signals recently picked up insider purchases at Culp Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 218 declarations
AdvanSix Inc. (ticker: ASIX) is a U.S.-listed company traded on the NYSE in the United States. It is a diversified chemistry business with a strong industrial materials profile, built around integrated manufacturing and a product set that serves global supply chains. AdvanSix was separated from Honeywell’s former Resins & Chemicals business and became an independent public company on October 1, 2016. The company is headquartered in Parsippany, New Jersey, and its operating footprint is primarily U.S.-based, with five manufacturing facilities in the United States supporting its industrial platform. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001673985/000167398526000008/asix-20251231.htm?utm_source=openai))
From an operating standpoint, AdvanSix focuses on essential chemistries rather than consumer-facing brands. Its portfolio includes nylon 6, caprolactam, ammonium sulfate, sulfuric acid, ammonia, and related chemical intermediates. The company sells into a broad range of end markets, including building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, and electronics. That mix gives AdvanSix exposure to multiple industrial demand drivers, but it also means earnings can be sensitive to feedstock costs, plant utilization, turnaround activity, and cyclical pricing conditions. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1673985/000167398525000011/asix-20241231.htm?utm_source=openai))
Competitively, AdvanSix occupies a niche position rather than that of a mega-cap commodity producer. Its strengths are vertical integration in key value chains, a domestic manufacturing base in the United States, and customer relationships in markets where supply reliability matters. Management continues to emphasize the strategic importance of its chemistry platform across building materials, agriculture, and performance applications. The company’s U.S. production base also supports logistics efficiency for North American customers, while its end markets and supply chains extend beyond the U.S. into international trade flows. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001673985/000167398526000008/asix-20251231.htm?utm_source=openai))
Recent news indicates a company still navigating a cyclical environment, but with some operational momentum. In February 2026, AdvanSix reported fourth-quarter 2025 sales of $360 million, up 9% year over year, and said its 2025 planned plant turnarounds were completed successfully at the low end of the expected range. Management highlighted initiatives aimed at improving 2026 cash flow through fixed-cost savings, turnaround scope optimization, risk-based capital spending prioritization, and tax benefits. In the third quarter of 2025, the company had already flagged weak conditions in Nylon Solutions and softer pricing in Chemical Intermediates, prompting lower production rates to manage inventory and protect free cash flow. ([advansix.com](https://www.advansix.com/advansix-announces-fourth-quarter-and-full-year-2025-financial-results/?utm_source=openai))
For French-speaking investors, ASIX can be viewed as a specialized U.S. chemical and materials name with cyclical earnings characteristics but a diversified end-market base. The key monitoring points are operating execution, maintenance turnaround discipline, pricing trends, raw material spread dynamics, and demand in fertilizers and performance chemicals. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1673985/000167398525000011/asix-20241231.htm?utm_source=openai))
Purchases our model currently ranks for the recommendations list.
All recommendationsInsider filings
Over the last 90 days, 1 filing published on 8 October 2026: no open-market purchase or sale filed by an insider. 1 other filing (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 14 October 2026 (UTC)
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2025 | 1.52 bn USD | 49.3 m USD | 1.80 USD | 10-K |
| Dec 2024 | 1.52 bn USD | 44.1 m USD | 1.62 USD | 10-K |
| Dec 2023 | 1.53 bn USD | 54.6 m USD | 1.95 USD | 10-K |
| Dec 2022 | 1.95 bn USD | 171.9 m USD | 5.92 USD | 10-K |
| Dec 2021 | 1.68 bn USD | 139.8 m USD | 4.81 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.